Alexis C. Komor
Molecular Biology · 2016–2017
A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 191 citations into it; #6,035 of 17,773 by trust here, #3,027 by citations
Whom Alexis C. Komor trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Alexis C. Komor overall
- Jordan L. Doman
- David R. Liu
- H. Rees
- Frank Hille
- Jennifer A. Doudna
- Aditya Raguram
- Andrew V. Anzalone
- Joy Y. Wang
- Luke W. Koblan
- Kunling Chen
Papers from Alexis C. Komor's perspective
Ordered by how strongly the researchers Alexis C. Komor trusts endorse each paper. Same corpus, a different order for every researcher.
- Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells
- RNA-Guided Human Genome Engineering via Cas9
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes (Science)
- High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA (Nature)
- Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. (Cell)
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes (Cell)
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
- RNA-programmed genome editing in human cells (eLife)
Their papers
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage (2017) — 5,379 citations
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage (2016) — 4,662 citations
- Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity (2017) — 708 citations
- CRISPR-based technologies for the manipulation of eukaryotic genomes (2016) — 992 citations
- Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions (2017) — 705 citations